300 results
Page 4 of 15
6-K
EX-99.1
7mygej7en 55itx1cvl
19 May 23
Current report (foreign)
12:48pm
6-K
EX-99.1
jx6n690tqc
10 May 23
Genmab Announces Financial Results for the First Quarter of 2023
11:23am
6-K
EX-99.1
l2mvg0fts bq
24 Apr 23
Genmab To File Appeal in Its Second Arbitration Under License Agreement with Janssen
8:58am
6-K
EX-99.1
40sd065busiitb2m
20 Apr 23
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen
8:18pm
6-K
EX-99.1
0897423l8nbsfi2e7
18 Apr 23
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2023
10:20am
6-K
EX-99.1
0cn2aa
6 Apr 23
Current report (foreign)
4:52pm
6-K
EX-99.1
ifqot90woexumm
3 Apr 23
Current report (foreign)
5:18pm
6-K
EX-99.1
wq3 y63uh6lzr
3 Apr 23
Completion of share buy-back program
11:14am
6-K
EX-99.2
nf7ver0tkc5hn51zty
29 Mar 23
Current report (foreign)
4:32pm
6-K
EX-99.1
3fulcx0bs5bw3z4qszgw
29 Mar 23
Current report (foreign)
4:32pm
6-K
EX-99.1
bhrfzz
29 Mar 23
Passing of Genmab A/S’ Annual General Meeting
10:05am
6-K
EX-99.1
d7b3oqbbtmap8y5gcl
14 Dec 22
Current report (foreign)
3:50pm
6-K
EX-99.1
jgv4r
13 Dec 22
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:54pm
6-K
EX-99.2
kz1mo
13 Dec 22
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:54pm
6-K
EX-99.1
3qz9nek5vv5
23 Nov 22
Current report (foreign)
3:14pm
6-K
EX-99.2
c7nygr4olb8bd
21 Nov 22
Current report (foreign)
2:55pm
6-K
EX-99.1
b5rzufs
21 Nov 22
Current report (foreign)
2:55pm
6-K
EX-99.1
kgp fbepp
15 Nov 22
Capital Increase in Genmab as a Result of Employee Warrant Exercise
2:05pm
6-K
EX-99.1
qqhl5san
14 Nov 22
Current report (foreign)
1:52pm
6-K
EX-99.1
caat3u5tw
9 Nov 22
Genmab Announces Financial Results for the First Nine Months of 2022
11:31am